185 related articles for article (PubMed ID: 33953831)
1. The Association of Polymorphisms in
Mihailovic S; Coric V; Radic T; Radojevic AS; Matic M; Dragicevic D; Djokic M; Vasic V; Dzamic Z; Simic T; Hadzi-Djokic J; Pljesa Ercegovac M
Oxid Med Cell Longev; 2021; 2021():6617969. PubMed ID: 33953831
[TBL] [Abstract][Full Text] [Related]
2. GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma.
Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic-Radojevic AR; Radojevic-Skodric SM; Matic MG; Suvakov SR; Dragicevic DP; Radic TM; Dzamic ZM; Pljesa-Ercegovac MS
Urol Oncol; 2017 Jun; 35(6):409-417. PubMed ID: 28284893
[TBL] [Abstract][Full Text] [Related]
3. The Association of Polymorphisms in Genes Encoding Antioxidant Enzymes GPX1 (rs1050450), SOD2 (rs4880) and Transcriptional Factor Nrf2 (rs6721961) with the Risk and Development of Prostate Cancer.
Djokic M; Radic T; Santric V; Dragicevic D; Suvakov S; Mihailovic S; Stankovic V; Cekerevac M; Simic T; Nikitovic M; Coric V
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295574
[No Abstract] [Full Text] [Related]
4. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
5. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer.
Yamaguchi Y; Kamai T; Higashi S; Murakami S; Arai K; Shirataki H; Yoshida KI
BMC Cancer; 2019 Nov; 19(1):1137. PubMed ID: 31752777
[TBL] [Abstract][Full Text] [Related]
7. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
[TBL] [Abstract][Full Text] [Related]
8. Association of RASSF1A genotype and haplotype with the progression of clear cell renal cell carcinoma in Japanese patients.
Kawai Y; Sakano S; Okayama N; Suehiro Y; Matsuyama H; Hinoda Y
BJU Int; 2012 Oct; 110(7):1070-5. PubMed ID: 22520501
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific association of methylenetetrahydrofolate reductase genotype and haplotype with the aggressiveness and prognosis of clear cell renal cell carcinoma in Japanese patients.
Sakano S; Hinoda Y; Okayama N; Kawai Y; Ito H; Nagao K; Hara T; Matsuyama H
BJU Int; 2010 Aug; 106(3):424-30. PubMed ID: 20039875
[TBL] [Abstract][Full Text] [Related]
10. Association of
Jerotic D; Matic M; Suvakov S; Vucicevic K; Damjanovic T; Savic-Radojevic A; Pljesa-Ercegovac M; Coric V; Stefanovic A; Ivanisevic J; Jelic-Ivanovic Z; McClements L; Dimkovic N; Simic T
Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31340563
[TBL] [Abstract][Full Text] [Related]
11. BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma.
Yu YP; Cai LC; Wang XY; Cheng SY; Zhang DM; Jian WG; Wang TD; Yang JK; Yang KB; Zhang C
Cancer Sci; 2020 May; 111(5):1555-1566. PubMed ID: 32128917
[TBL] [Abstract][Full Text] [Related]
12. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
[TBL] [Abstract][Full Text] [Related]
13. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
[TBL] [Abstract][Full Text] [Related]
14. Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma.
Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic Radojevic AR; Radojevic-Skodric SM; Matic MG; Dragicevic DP; Radic TM; Bogdanovic LM; Dzamic ZM; Pljesa-Ercegovac MS
PLoS One; 2016; 11(8):e0160570. PubMed ID: 27500405
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.
Xu Z; Zhu H; Luk JM; Wu D; Gu D; Gong W; Tan Y; Zhou J; Tang J; Zhang Z; Wang M; Chen J
Cancer; 2012 Nov; 118(22):5489-96. PubMed ID: 22517484
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
17. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
19. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
20. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]